Related Experiment Video
Updated: Jun 29, 2025
Chinese Herbal Retention Enema for the Treatment of Ulcerative Colitis
Published on: May 16, 2025
Integrated Virtual Care for Irritable Bowel Syndrome: A Qualitative Study.
Louise Babikow1,2,3,4, Tonks N Fawcett1,2,3,4, Elizabeth Pfeifer1,2,3,4
1Louise Babikow, MScR, RN, CRNP, is Student at School of Health in Social Sciences, The University of Edinburgh, Scotland, United Kingdom.
This pilot study explored patient experiences with virtual, multidisciplinary irritable bowel syndrome (IBS) care. Findings highlight themes of system issues and patient empowerment through telemedicine services.
Area of Science:
- Gastroenterology
- Digital Health
- Patient Experience Research
Background:
- Irritable bowel syndrome (IBS) affects ~10% of the US population, yet effective understanding, diagnosis, and treatment remain challenging.
- The rise of health-tech companies offers integrated IBS treatment via telemedicine, necessitating research into patient experiences.
Purpose of the Study:
- To explore the patient experience of virtual, multidisciplinary IBS care provided by Oshi Health.
- To identify common themes in patient perspectives regarding telemedicine for IBS management.
Main Methods:
- Pilot study utilizing semistructured interviews with patients receiving virtual IBS care.
- Thematic analysis was employed to identify overarching patient experience themes.
Main Results:
- Identified overarching themes: "loss of the grocer," "a broken system," and "the power of self-trust."
- These themes provide insight into patient perceptions of current IBS care models and the impact of virtual multidisciplinary approaches.
Conclusions:
- Telemedicine offers a novel approach to integrated IBS care, though system-level challenges persist.
- Further research with larger sample sizes is needed to validate findings and inform future digital health strategies for IBS.
Related Concept Videos
01:30Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
01:17Irritable Bowel Syndrome I: Introduction
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
01:30Irritable Bowel Syndrome III: Medical and Nursing Management
01:17Drugs for Treatment of Diarrhea-Predominant IBS
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
01:21Drugs for Treatment of Constipation-Predominant IBS
01:17Assessment of the Gastrointestinal System I: Subjective Data
Health History
The initial step in assessing the GI system is obtaining a comprehensive health history. This includes inquiring about the patient's history or presence of problems...